There's growing calls to find pathways to bring CAR-T cell therapy to New Zealand.

The current trial of the life changing cancer treatment is set to end at later this year, but there's no clear path to making it available through the public health system.

Malaghan Institute Clinical Director Rob Weinkove says this treatment will improve many people's outcomes.

"Much of the infrastructure is there and I think one of the main motivations of setting up this trial here is just to skill up, because it's clear the big international pharmacies weren't going to come to New Zealand, we're a small market."

LISTEN ABOVE

There's growing calls to find pathways to bring CAR-T cell therapy to New Zealand.
The current trial of the life changing cancer treatment is set to end at later this year, but there's no clear path to making it available through the public health system.
Malaghan Institute Clinical Director Rob Weinkove says this treatment will improve many people's outcomes.
"Much of the infrastructure is there and I think one of the main motivations of setting up this trial here is just to skill up, because it's clear the big international pharmacies weren't going to come to New Zealand, we're a small market."
LISTEN ABOVE

News, opinion, analysis, lifestyle and entertainment – we’ve got your Sunday morning listening covered with The Sunday Session with Francesca Rudkin on Newstalk ZB.

The Sunday Session with Francesca Rudkin

Rob Weinkove: Malaghan Institute Clinical Director on his bid to bring CAR-T cell therapy to NZ

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/51bf58bc-ace7-4fc4-96db-b3f1016db86d/transcript